Docebo Overview
Docebo Target Price
Analysts' 12-month price predictions for DCBO.
Share Price
$28.77
Average Target Price
$43.00
49.5% upside
49.5% upside2 analysts in the last 4 months
High: $45 | Low: $41
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-16 | Morgan StanleyJosh Baer | $41 | 42.5% upside |  |
| 2025-03-04 | UBS | $45 | 56.4% upside | |
| 2025-02-28 | Morgan Stanley | $43 | 49.5% upside | |
| 2024-10-24 | ScotiabankKevin Krishnaratne | $55 | 91.2% upside | |
| 2024-09-16 | Goldman SachsKevin Kumar | $48 | 66.8% upside | |
| 2024-09-12 | NeedhamRyan MacDonald | $50 | 73.8% upside | |
| 2024-08-09 | Canaccord GenuityRobert Young | $54 | 87.7% upside | |
| 2024-06-07 | Craig-HallumGeorge Sutton | $58 | 101.6% upside | |
| 2024-05-14 | Canaccord GenuityRobert Young | $55 | 91.2% upside | |
| 2024-05-14 | ScotiabankKevin Krishnaratne | $50 | 73.8% upside | |
| 2023-11-14 | NeedhamRyan MacDonald | $56 | 94.6% upside | |
| 2023-08-18 | Morgan StanleyJosh Baer | $49 | 70.3% upside | |
| 2022-11-11 | Morgan Stanley | $36 | 25.1% upside | |
| 2022-04-26 | Morgan Stanley | $54 | 87.7% upside | |
| 2021-08-13 | Cantor FitzgeraldBrett Knoblauch | $82 | 185% upside | |